SCHEMBL5558757

SCHEMBL5558757

O=C1c2ccccc2C(=O)N1OCc1ccc2ncccc2c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ CYP1B1 Q16678 1/20 0.47
▸ POLB P06746 2/20 0.46
▸ PSMD14 O00487 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ MMP2 P08253 1/20 0.46
▸ MET P08581 5/20 0.44
▸ DAO P14920 1/20 0.43
▸ HDAC3 O15379 2/20 0.42
▸ GAA P10253 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ CHKA P35790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5554044 0.84 MEN1 (0.51) MEN1MAPTKMT2AGAAALDH1A1
SCHEMBL5558141 0.82 MEN1 (0.62) MEN1MAPTKMT2APOLBGAA
SCHEMBL1163336 0.80 CYP1B1 (0.69) MEN1MAPTKMT2ACYP1B1POLB
SCHEMBL661305 0.76 MEN1 (0.55) MEN1MAPTKMT2APOLBGAA
SCHEMBL5528668 0.72 MEN1 (0.66) MEN1MAPTKMT2APOLBGAA
SCHEMBL1520828 0.72 ALDH1A1 (0.53) MEN1MAPTKMT2APOLBTP53
SCHEMBL3136961 0.72 ALDH1A1 (0.53) MAPTPOLBTP53METDAO
SCHEMBL3365048 0.72 HDAC6 (0.49) MEN1MAPTKMT2APOLBTP53
SCHEMBL28714141 0.72 HDAC3 (0.50) MEN1MAPTKMT2APOLBTP53
SCHEMBL7274371 0.72 NPC1 (0.47) MEN1MAPTKMT2APOLBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39591-E1 6-O-substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2007-04-24 — — US disclosed
EP-1291351-B1 6-0 substituted ketolides having antibacterial activity ABBOTT LAB (US) 2005-07-13 — — EP disclosed
EP-1291353-B1 6-O-substituted ketolides having antibacterial activity ABBOTT LAB (US) 2005-06-01 — — EP disclosed
EP-0929563-B1 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY ABBOTT LAB (US) 2005-06-01 — — EP disclosed
EP-1291352-B1 6-O-substituted ketolides having antibacterial activity ABBOTT LAB (US) 2005-05-25 — — EP disclosed
EP-1291350-B1 6-0 substituted ketolides having antibacterial activity ABBOTT LAB (US) 2005-05-25 — — EP disclosed
EP-1291351-A1 6-0 substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2003-03-12 — — EP disclosed
EP-1291352-A1 6-O-substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2003-03-12 — — EP disclosed
EP-1291350-A1 6-0 substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2003-03-12 — — EP disclosed
EP-1291353-A1 6-O-substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2003-03-12 — — EP disclosed
US-6147197-A INCREASED ACID STABILITY AND ENHANCED ACTIVITY TOWARD GRAM NEGATIVE BACTERIA AND MACROLIDE RESISTANT GRAM POSITIVE BACTERIA ABBVIE INC. 2000-11-14 — — US disclosed
US-6075133-A INCREASED ACID STABILITY AND ENHANCED BACTERICIDAL ACTIVITY ABBOTT LABORATORIES (US) 2000-06-13 — — US disclosed
US-6028181-A 6-0-Substituted antibacterial erythromycin ketolides and methods of making ABBOTT LABORATORIES (US) 2000-02-22 — — US disclosed
EP-0929563-A1 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY Abbott Laboratories (US) 1999-07-21 — — EP disclosed
US-5866549-A MACROLIDE ANTIBIOTICS ABBOTT LABORATORIES (US) 1999-02-02 — — US disclosed
WO-1998009978-A1 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY ABBOTT LABORATORIES (US) 1998-03-12 — — WO disclosed
Send feedback